Churchill P C, Bidani A K
Med Hypotheses. 1982 Mar;8(3):275-85. doi: 10.1016/0306-9877(82)90124-4.
The decreased filtration fraction and glomerular filtration rate characteristic of renal failure could be produced, at least in part, by increased concentration of an endogenous substance which constricts afferent and dilates efferent arterioles. Adenosine satisfies several criteria: (a) exogenous adenosine and its precursors decrease filtration fraction and glomerular filtration rate; (b) the kidneys produce and release adenosine, and production and release are augmented during conditions associated with the induction of renal failure--hypoxia, ischemia, and renal vasoconstriction; (c) several substances known to antagonize adenosine-uptake processes in some cells, which could thereby increase extracellular adenosine concentration, not only have "adenosine-like" effects on the kidney but also induce and/or potentiate existing renal failure. A corollary of this hypothesis is that adenosine-receptor antagonists, such as the methylxanthines, should counteract the hemodynamic changes characteristic of renal failure. It has been known for several years that aminophylline (1,3-dimethylxanthine ethylenediamine) increases the filtration fraction and the glomerular filtration rate.
肾衰竭所特有的滤过分数降低和肾小球滤过率降低,至少部分是由一种内源性物质浓度升高所致,该物质可使入球小动脉收缩,出球小动脉扩张。腺苷符合多项标准:(a)外源性腺苷及其前体可降低滤过分数和肾小球滤过率;(b)肾脏可产生并释放腺苷,且在与肾衰竭诱导相关的情况下——缺氧、缺血和肾血管收缩时,其产生和释放会增加;(c)几种已知可拮抗某些细胞中腺苷摄取过程从而增加细胞外腺苷浓度的物质,不仅对肾脏有“腺苷样”作用,还会诱导和/或加重现有的肾衰竭。该假说的一个推论是,腺苷受体拮抗剂,如甲基黄嘌呤类药物,应可抵消肾衰竭特有的血流动力学变化。数年来已知氨茶碱(1,3 - 二甲基黄嘌呤乙二胺)可提高滤过分数和肾小球滤过率。